文献速递血栓与止血

PF4/多阴离子ELISA阴性的致病性抗体与肝素诱导的血小板减少症

Pathogenic PF4/Polyanion ELISA-Negative Antibodies in HIT.
PubMed 文献 · Am J Hematol · 2026-05-02

研究在疑似肝素诱导的血小板减少症(HIT)患者中发现了PF4/多阴离子ELISA阴性的血小板活化抗体。通过功能试验在500例ELISA阴性患者中额外识别出3例,共6例ELISA阴性HIT患者,其中5例再次暴露肝素后均出现血小板计数下降,1例发生新血栓。结论强调识别ELISA阴性HIT对避免停用替代抗凝及肝素再暴露危害至关重要。

要点

  • PF4/PVS ELISA阴性不能完全排除HIT,需警惕功能性抗体存在。
  • ELISA阴性但功能试验阳性的HIT患者再暴露肝素可致血小板下降或血栓。
  • 对临床高度怀疑HIT而ELISA阴性者,应考虑PF4依赖性功能试验。

核心结论

  • 识别ELISA阴性HIT对避免因停用替代抗凝及肝素再暴露造成的伤害至关重要。

研究设计与样本

  • 采用抗原为基础及PF4依赖性功能试验,研究疑似HIT患者中PF4/多阴离子ELISA阴性的血小板活化抗体。
  • 对500例ELISA阴性患者进行功能试验筛查。

主要发现

  • 3例临床表现符合HIT的患者在PF4/PVS ELISA中阴性,但功能试验显示PF4依赖性血小板活化,可被FcγRIIa受体阻断和高浓度肝素抑制。
  • 500例ELISA阴性患者功能筛查额外发现3例血清以PF4和FcγRIIa依赖方式活化血小板且临床病史符合HIT的患者。
  • 6例ELISA阴性HIT患者中5例再次暴露肝素,所有再暴露者均出现血小板计数下降,1例发生新血栓。

关键数值与推荐

  • PF4/PVS ELISA阴性结果被现行实践指南推荐用于排除HIT。
  • 功能试验中血小板活化需PF4依赖、FcγRIIa受体阻断敏感且高浓度肝素可抑制,符合致病性HIT抗体特征。

临床怎么用

  • 对临床高度怀疑HIT但PF4/PVS ELISA阴性的患者,不应仅凭ELISA阴性排除HIT。
  • 此类患者应避免贸然停用非肝素抗凝及再次暴露肝素,可考虑PF4依赖性功能试验辅助诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Platelet factor 4-polyanion enzyme-linked immunosorbent assays (ELISAs) are considered highly sensitive for diagnosing heparin-induced thrombocytopenia (HIT), such that current practice guidelines recommend use of ELISA-negative results to exclude HIT. Once HIT is ruled out, alternative, non-heparin-based anticoagulant treatments are ceased, and heparin reintroduction frequently occurs. METHODS: Antigen-based and PF4-dependent functional testing were used to study PF4/polyvinylsulfonate ELISA-negative platelet-activating antibodies in HIT-suspected patients. RESULTS: Three patients with clinical presentations consistent with HIT tested negative in an ELISA using PF4-polyvinylsulfonate (PF4/PVS), an antigenic target very commonly used for HIT antibody screening. All three patients demonstrated PF4-dependent platelet activation in functional testing that was sensitive to blockade of platelet FcγRIIa receptors and inhibited by high concentrations of heparin, consistent with pathogenic HIT antibodies. Functional testing-based screening of 500 ELISA-negative patients identified three additional patients whose sera activated platelets in a PF4- and FcγRIIa-dependent manner and had clinical histories consistent with HIT. Five of the six ELISA-negative HIT patients were re-exposed to heparin, which precipitated a decrease in platelet counts in all re-exposed patients, and one patient developed a new thrombus. CONCLUSIONS: Recognition of ELISA-negative HIT is critical to avoid harm due to the cessation of alternative anticoagulation therapy and re-exposure of these patients to heparin.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Kanack AJ, Splinter NP, Mauch EE, et al. Pathogenic PF4/Polyanion ELISA-Negative Antibodies in HIT. Am J Hematol. 2026. PMID: 42068120. doi:10.1002/ajh.70333

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。